US Broker Ratings

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with 56.72% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands out in the biotechnology industry, not only for its innovative approach to therapeutics but also for its compelling growth prospects that position it as..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Healthcare Giant with a 15% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices sector, is drawing the attention of investors with its robust market position and promising growth potential. Headquartered..

Haleon plc (HLN): Investor Outlook on a 19.94% Potential Upside in Healthcare Stocks

As the healthcare sector continues to demonstrate resilience in a fluctuating global market, Haleon plc (HLN) emerges as a compelling opportunity for investors seeking exposure to drug manufacturers specializing in..

Abbott Laboratories (ABT) Stock Analysis: Navigating Growth in the Healthcare Sector with a 13% Revenue Surge

Abbott Laboratories (NYSE: ABT), a prominent player in the healthcare sector, continues to capture investor attention with its strong revenue growth and robust product offerings. As a leader in the..

Novartis AG (NVS) Stock Analysis: Exploring Its Current Valuation and Growth Potential

Novartis AG (NVS), a Swiss-based global healthcare giant, continues to capture the attention of investors with its expansive pharmaceutical portfolio and robust market presence. With a market capitalization of $301.95..

Incyte Corporation (INCY) Stock Analysis: Evaluating Growth Potential Amidst Strong Revenue Surge

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, continues to captivate investors with its robust revenue growth and diverse drug portfolio. As of the latest trading session,..

Novo Nordisk A/S (NVO): Investor Outlook with Strong Dividend Yield and Impressive ROE

Novo Nordisk A/S (NVO), a titan in the healthcare sector, stands out as a formidable force in the drug manufacturing industry, with a market capitalization of $206.69 billion. Headquartered in..

ICON plc (ICLR) Stock Analysis: Navigating Growth in Diagnostics & Research with a 7.74% Upside

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, offers intriguing potential for investors, particularly within the diagnostics and research industry. Headquartered in Dublin, Ireland, ICON operates on..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 36.49% Potential Upside in the Biotech Sector

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology industry, focusing on the development and commercialization of therapies for rare diseases. With a market capitalization of..

Agilent Technologies, Inc. (A) Stock Analysis: Evaluating Growth Potential in the Diagnostics Sector

Agilent Technologies, Inc. (NYSE: A), a major player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with its robust market performance and strategic industry positioning. With..

Royalty Pharma plc (RPRX) Stock Analysis: Strong Buy Ratings and Promising Growth in the Biotech Sector

Royalty Pharma plc (NASDAQ: RPRX) stands as a distinctive player in the biotech sector, leveraging its unique business model to generate robust returns. Based in New York, this U.S.-based company..

Takeda Pharmaceutical (TAK) Stock Analysis: Exploring a 20.85% Potential Upside in the Healthcare Sector

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent name in the healthcare sector, commands attention with its impressive market cap of $58.06 billion and a robust portfolio spanning gastroenterology, rare..

Stryker Corporation (SYK) Stock Analysis: 16% Potential Upside Beckons Investors

Stryker Corporation (NYSE: SYK), a prominent player in the healthcare sector, stands out in the medical devices industry with a market capitalization of $126.37 billion. Headquartered in Portage, Michigan, Stryker..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with Mixed Growth Signals

Revvity, Inc. (NYSE: RVTY) is a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry. As a U.S.-based company, Revvity offers a broad range of health..

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking the 16.3% Revenue Growth in the Healthcare Cloud Sector

Veeva Systems Inc. (NYSE: VEEV), a prominent player in the healthcare information services sector, continues to capture investor attention with its robust revenue growth and strategic positioning in the cloud-based..

Amgen Inc. (AMGN) Investor Outlook: Exploring the Balance of Growth and Dividend Appeal

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust portfolio of therapeutics and a significant market cap of $237.52..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential Amidst a 6.13% Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a robust market capitalization of $159.99 billion, Pfizer’s comprehensive suite..

Insmed Incorporated (INSM): Analyst Consensus Projects 59% Upside—A Biotech Powerhouse with Robust Growth Potential

Investors with an appetite for biotechnology stocks may find Insmed Incorporated (NASDAQ: INSM) an intriguing prospect. With a current market capitalization of $27.47 billion, Insmed is making significant strides in..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring Growth Potential with a Robust Pipeline and Strategic Alliances

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, captivating investor interest with its innovative therapeutic developments and strategic collaborations. With a market capitalization of..

ResMed Inc. (RMD) Stock Analysis: Navigating a 6.04% Potential Upside Amidst Growth and Stability

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is making waves with its innovative digital health and cloud-connected medical devices. With a market capitalization of $33.4 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds